Introduction
RNA interference has become one of the most important new tools for biological research in the past decade. [1] This methodology is widely used for knocking down (i.e., regulating) expression of specific genes in cell culture and can be carried out conveniently by using synthetic 21-23 nt double-stranded RNAs, which are known as short interfering RNAs or siRNAs. [2] These oligoribonucleotides each consist of a sense and an antisense (or guide) strand, which is complementary in sequence to a fragment of the target mRNA. The RNAi process is initiated with the recognition of the siRNA duplex by the RNA-induced silencing complex (RISC), [3] a protein located in the cytoplasm. After siRNA binding, RISC uses the antisense strand as a template to find the target mRNA [4] and induces endonucleolytic cleavage of the target mRNA, [5] preventing its translation into protein.
Despite the significance of RNAi both as a biological tool and as a potential therapeutic strategy, the utility of siRNAs in vivo faces some key hurdles, including delivery, biostability, [6] and low sequence specificity that results in undesired offtarget effects. [7] Moreover, cellular receptors such as toll-like receptors can bind to siRNAs and trigger innate immune responses, resulting in cytokine production. [8] To address these limitations and to advance understanding of the mechanism of silencing further, several research groups have been actively studying siRNAs with various chemical modifications, [9] especially on the sugar moiety. [10] One widely used class of alteration that has been explored involves restriction of the conformations of the furanose systems of the nucleotide building blocks of siRNAs to the North hemisphere of the pseudorotational cycle, [11] which is promis-ing for the development of a nucleic acid analogue with high binding affinity to its RNA complement. Among this class of modifications, incorporation of appropriate electronegative substituents at the 2'-position in the sugar ring [12] -such as 2'fluoro [10a, b] and 2'-O-methyl substitutions in the ribo configuration [10a-c] -has been found to increase the stabilities of siRNAs to degradation by nucleases and to improve thermal stability, as measured by T m values. Moreover, Aigner et al. recently described siRNAs containing 2'-azido substitution. [10d] Interestingly, they found that this modification is well accepted by the RNAi machinery.
Another 2'-sugar modification that has been investigated involves the addition of a methylene bridge between the 2'oxygen and the 4'-carbon of the furanose ring. [13] The resulting
North bicyclo methanocarba thymidine (T N ) nucleosides were substituted into siRNAs to investigate the effect of bicyclo-[3.1.0]hexane 2'-deoxy-pseudosugars on RNA interference activity. Here we provide evidence that these modified siRNAs are compatible with the intracellular RNAi machinery. We studied the effect of the T N modification in a screen involving residue-specific changes in an siRNA targeting Renilla luciferase and we applied the most effective pattern of modification to the knockdown of murine tumor necrosis factor (TNF-a). We also showed that incorporation of T N units into siRNA duplexes increased their thermal stabilities, substantially enhanced serum stabilities, and decreased innate immunostimulation. Comparative RNAi studies involving the T N substitution and locked nucleic acids (LNAs) showed that the gene-silencing activities of T N -modified siRNAs were comparable to those obtained with the LNA modification. An advantage of the North 2'-deoxy-methanocarba modification is that it may be explored further in the future by changing the 2'-position. The results from these studies suggest that this modification might be valuable for the development of siRNAs for therapeutic applications.
nucleotides and oligonucleotides containing these monomers are called "locked nucleic acids" (LNAs) [14] because the conformations of the bicyclic furanose rings are locked in the North hemisphere of the pseudorational cycle (3'-endo conformation), [11] thus retaining conformationally RNA-like A-type helical characteristics for effective gene silencing. Several studies have demonstrated that the LNA modification increases the thermodynamic and serum stabilities of siRNA duplexes to a great extent [10e, i, 15] and that single RNA-to-LNA exchanges at basepaired positions in the antisense strand are tolerated in most of the positions that have been investigated. [10e] Other conformationally restricted nucleoside analogues have been synthesized and incorporated into oligonucleotide strands. [16] Examples include bicyclodeoxynucleosides, [16a, b] containing ethylene bridges between the 3'-and the 5'-carbons of their furanose rings, and tricyclodeoxynucleosides, [16c-g] with additional cyclopropane rings fused to the ethylene bridges. The resulting oligonucleotides containing these units are called bc-DNAs and tc-DNAs, respectively. In particular, tc-DNA modifications have been found to favor A-form double helixes. [16e] In recent studies, Ittig et al. have found that incorporation of tc-DNA units in various positions of siRNAs can improve RNAi activities and serum stabilities. [16g] Another candidate for introducing new features into siRNAs without perturbing the overall A-form helical structures required for activity is the North-locked form of 2'-deoxynucleoside analogues based on a carbocyclic bicyclo[3.1.0]hexane system [2'-deoxy-methanocarba (MC) nucleosides]. [17] The design and synthesis of 2'-deoxy-MC nucleosides have been summarized. [18] Moreover, it has been found that incorporation of North 2'-deoxy-MC thymidine (T N ) units into oligodeoxynucleotide strands increases the thermal stabilities of the corresponding ODN/RNA heteroduplexes. [17b, 18b] Despite the efficient hybridization of North 2'-deoxy-MC nucleoside analogues, however, these derivatives have never been incorporated into RNA strands and have therefore never been tested for their effects on the RNAi process. In this work we explore the replacement of the natural sugar rings in siRNAs by North conformationally restricted carbocyclic bicyclo[3.1.0]hexane systems. In particular, we focus on siRNAs modified with the North 2'-deoxy-MC thymidine derivative (T N ). Here we report studies in which the gene-silencing efficiencies of T N -modified siRNAs and native siRNA molecules are directly compared. In particular, we focus mainly on the modification of the guide strands, which have been reported to be more sensitive to chemical modification than the sense strands. [10a, 19] Because of the importance of the guide strand in the RNAi process, modification of this strand can provide useful information on the RNAi mechanism and also on guide siRNA-RISC interactions. However, most of the focus to date has been on modifying the sense strand, which tolerates chemical modification better. [10e] To carry out such a study, we first evaluated the effect of the T N modification on the abilities of siRNAs to inhibit the expression of a luciferase gene. In addition, we studied the use of this modification for inhibiting the expression of the murine tumor necrosis factor (TNF-a) gene. This research is an ongoing project directed towards the search for anti-inflammatory siRNAs to treat Crohn's disease. A critical issue in the design of anti-inflammatory siRNAs is the inhibition of innate immune response. In this work, we also demonstrate that RNA to T N replacement decreases immunostimulation.
Moreover, we also evaluated the effects of these substitutions on the thermal and serum stabilities of the corresponding siRNA duplexes. We also compared the gene-silencing activities of two T N -modified siRNAs and their LNA thymine (T L )modified versions. Our results suggest that the RNAi activities of our T N -modified siRNAs were comparable to those of their T L -modified versions. These properties and the fact that a 2'deoxy-methanocarba nucleoside has an open 2'-position allows the exploration of chemical diversity at this site to give new, North MC-modified siRNAs with yet unexplored therapeutic applications.
Results and Discussion
Design and synthesis of modified guide and sense strands targeting the Renilla luciferase gene
We first designed a large number of 21-mer T N -modified siRNA duplexes targeting the A-rich site 501-519 of Renilla luciferase mRNA [9d, e, g] (Figure 1 B) . We chose a luciferase model system because it allowed rapid determination of RNAi activity. This sequence allowed us to make a large number of substitutions into the guide strand through use of the T N monomer (replacement of natural U by T N ). The North 2'-deoxy-MC thymidine monomer was synthesized according to the literature. [17b] This modification could be introduced into RNA without substantial alteration of standard synthesis protocols (see the Experimental Section).
We synthesized siRNAs variously containing no modifications (1), a single T N substitution at positions 1 (2), 2 (4), 10 (5), 11 (6) , and 20 (7) in the guide strand, one modification at both ends of the guide strand (8) , three modifications on the 5'-half (9) and three modifications on the 3'-half (10) , six T N substitutions at spaced-out positions along the guide strand (11) , and eleven T N substitutions (12). We also modified the 3'-dinucleo-tide overhangs to give the siRNAs 13 (modification of the guide strand), 14 (modification of the sense strand), and 15 (modification of both strands). Moreover, we also prepared the siRNA 16, which contains a single T N substitution at position 2 in the sense strand, and the 5'-phosphorylated version of the siRNA 2 (3). Finally, we synthesized LNA-modified versions of the siRNAs 7 and 11 (17 and 18) , in order to compare their RNAi activities.
Thermal stabilities of North methanocarba thymidinemodified siRNA duplexes
After RNA synthesis we measured the effects of these substitutions on the thermal stabilities of the siRNA duplexes ( Figure 1 B) . Thermal stability is an important variable to evaluate when considering the value of chemical modifications to siRNA. It can play a substantial role in, for example, the stability of the duplex towards degradation by nucleases, because formation of thermodynamically stable duplexes can prevent the degradation of the constituent RNA strands by single-stranded nucleases. On the other hand, the level of siRNA duplex stability is also a critical parameter for siRNA activity. [10a] However, it has been suggested that there is a limit to how stable the duplex can be. In work by Chiu et al. it was reported that excessive thermal duplex stabilization can interfere with siRNA unwinding. [10a] All of the substituted oligoribonucleotides containing T N substitutions at base-paired positions had greater duplex stabilities (as evaluated by higher T m values) than the unmodified RNA sequence (1), when hybridized to their RNA complements (see data in Figure 1 B ). The incorporation of North 2'-deoxy-MC thymidine residues resulted in increases of 0.8-2 8C per modification, depending on the position of the pseudonucleoside. Such stabilizing effects were found to be additive. This is consistent with the previously reported thermodynamic stabilities of T N -modified ODN/RNA heteroduplexes. [18a, c] The rank order of duplex T m was: eleven T N (12) > six T N (11) > three T N on the 5'-half (9) > three T N on the 3'-half (10)-one T N at position 10 in the guide strand (5) > one T N at position 11 (6) > one T N at position 2 in the guide strand (4 and 8)-one T N at position 2 in the sense strand (16) and one T N at position 1 in the guide strand (2).
A singly modified LNA-siRNA duplex was as stable as the corresponding T N -siRNA duplex (17 and 7), whereas an LNA-siRNA with multiple substitutions was more stable than the corresponding T N -siRNA duplex [T m = 79.7 8C for siRNA 18 (containing six T L residues) versus T m = 72.8 8C for its T N -modified version (11) ].
CD spectra of T N -modified siRNA duplexes
We determined CD spectra of selected siRNAs [siRNAs containing no modifications (1), one T N unit (5), two T N units (8), three T N units (9), six T N units (11) and eleven T N units (12)]. The spectra clearly indicate that the overall conformation of a typical A-form double helical geometry is retained in the T N -modified siRNAs (see Figure S5 in the Supporting Information).
RNAi activities of T N -modified siRNAs targeting the Renilla luciferase gene
RNAi studies were performed in SH-SY5Y cells with siRNAs containing each of the eleven T N -modified guide strands (2-12), siRNAs modified at the 3'-dinucleotide overhangs (13) (14) (15) , siRNA 16 (containing a single T N substitution into the sense strand), as well as with the unmodified (wild-type) RNA (1) . Experiments were carried out in triplicate. The cells were first transfected with dual reporter plasmids that express Renilla luciferase (the target) and non-targeted firefly luciferase as an internal control. The effects of the different RNAs on luciferase expression were evaluated after dosing with double-stranded RNA (0.21-210 ng, 0.03-26 nm) in the cell media, and measurement of luminiscence responses after 22 h. The results, showing Renilla luciferase activity normalized to firefly luciferase, are represented in Figure 1 A.
In a first series of experiments, we compared the effects of the position of the T N modification on RNAi by making single RNA-to-T N exchanges at relevant base-paired positions in the guide strand (siRNAs 2-7, Figure 1 B ). It has been suggested that position 1 in the guide strand plays a critical role for siRNA function and is more sensitive to chemical modification. Incorporation of one T N residue at the 5'-end of the guide strand (position 1, siRNA 2) caused a significant decrease in luciferase activity relative to the unmodified or wild-type siRNA (1) at the highest siRNA concentration (26 nm). It is known that a 5'-phosphate is crucial for siRNA function; therefore, to exclude the possibility that the 5'-modified siRNA 2 was poorly recognized by cellular kinases, resulting in loss of activity due to the lack of a 5'-phosphate, we synthesized the 5'-phosphorylated version of the siRNA 2 (3). However, this procedure did not result in recovery of any of the lost effect (Figure 1 A) .
In contrast to what had been observed for compound 2, incorporation of a T N residue at position 2 in the guide strand (4) gave rise to a gene-silencing activity comparable to that of the wild-type siRNA (1) .
We next examined the effect of incorporation of a T N residue at position 10 in the guide strand (5). It is known that this position also plays an important role for the siRNA function, because mRNA cleavage occurs between positions 10 and 11 in Figure 1 . A) Plot of gene-specific RNAi activity for T N -modified siRNAs targeting the Renilla luciferase mRNA in SH-SY5Y cells. Various amounts of siRNAs were added as shown. B) Sequences of unmodified, T N -modified, and TL-modified siRNAs targeting the Renilla luciferase mRNA and T m data. Top strand depicts the sense strand in the 5'!3' direction (same as the target sequence). Bottom strand depicts the antisense strand in the 3'!5' direction (complementary to the target). T N : North methanocarba thymidine monomer. T L : LNA thymidine monomer. Scr: scrambled sequence. C) Plot comparing the gene-silencing activities of the North methanocarba thymidine-modified siRNAs 7 and 11 and the LNA-modified siRNAs 17 and 18 targeting the Renilla luciferase mRNA in SH-SY5Y cells. Untreated cells: cells treated with plasmids alone. Bars indicate standard deviation. the guide strand, counting from the 5'-end. When we incorporated a T N residue at position 10 in the guide strand we observed a decrease in gene-silencing activity. However, the resulting modified siRNA (5) retained significant activity [at the lowest siRNA concentration (0.03 nm), Renilla luciferase expression was~83 % for 5 and~68 % for wild-type siRNA (1)].
In contrast, RNA-to-T N replacement at position 11 did not disrupt RNAi activity. The siRNA 6 displayed gene-silencing activity comparable to that observed for the wild-type siRNA (1) . Moreover, guide siRNA with one T N substitution at position 20 (7) displayed slightly better activity than that observed for the unmodified siRNA 1. The most significant differences were observed when very low concentrations (0.03 nm) of siRNAs were employed [significant differences were assessed by ANOVA to compare three or more groups followed by a Bonferroni test (see data in Figure S1 A)]. At the lowest siRNA concentration (0.03 nm), there was (44 AE 3) % gene knockdown for 7, versus (32 AE 4) % for 1 (p < 0.05). It is noteworthy that this 3'-modified siRNA (7) displayed slightly better activity than the 5'-modified siRNA 4 (T N at position 2).
The experiments described above suggest that, with a few exceptions, siRNAs containing single substitutions in their guide strands could effectively mediate RNAi activity to levels comparable to the wild-type siRNA, and so it was of interest to study the effect of multiple substitutions on RNAi activity. We first incorporated one T N substitution at both ends of the guide strand (positions 2 and 20, siRNA 8). The resulting disubstituted siRNA displayed RNAi activity similar to that observed for the wild-type siRNA (1). On the other hand, incorporation of three T N residues in the 5'-half (positions 2, 4, and 7, siRNA 9) caused a slight loss of interference activity. Although the resulting modified siRNA (9) was significantly active, it showed decreased activity relative to the siRNA containing two T N residues (8) . However, incorporation of three substitutions in the 3'-half (positions 14, 19 and 20, siRNA 10) recovered all the lost effect. The siRNA 10 displayed gene-silencing activity slightly better than that of the siRNA 9 and comparable to that of the wild-type siRNA 1 (Bonferroni test, p < 0.05; see Figure S1 B) at an siRNA concentration of 0.03 nm, Renilla luciferase gene-silencing was (25 AE 7) % for 8, (20 AE 8) % for 9, (28 AE 3) % for 10, and (32 AE 4) % for 1. These effects and those described above (for the siRNAs 4 and 7, each containing a single T N substitution, at the 5' or the 3'-end, respectively) support the idea that the sequence structure in the 5'-region of the antisense strand is more sensitive to chemical modification than that in the 3'-region. [10a] This is also consistent with previous observations that incorporation of 2'-FU, 2'-FC, dAs, and dGs residues predominantly on the 5'-half of a siRNA caused a significant loss of gene-silencing activity, whereas siRNAs containing 2'-FU, 2'-FC, dAs and dGs modifications predominantly on the 3'-half retained significant levels of gene-silencing activity. [10a] Having demonstrated that three T N substitutions can be tolerated by the RNAi machinery, we studied the effects of higher numbers of substitutions in the guide strand. For the siRNA containing six T N substitutions at spaced-out positions along the guide strand (11), gene-silencing activity was significantly less efficient than that observed for wild-type, disubstituted, and trisubstituted siRNAs (1, 8 , and 9 and 10, respectively). However, despite this loss of activity, the siRNA 11 retained a significant inhibitory effect at the highest dose of 26 nm (ca. 12 % Renilla luciferase expression for 11 versus~4 % for 1).
In order to ensure that the loss of activity observed for the double-stranded 11 was due to the presence of excessive modifications we incorporated eleven T N residues in the antisense strand (12). As expected, the fully substituted siRNA 12 disrupted Renilla luciferase-specific RNAi activity. Incorporation of eleven T N substitutions within the guide strand caused the loss of most of the interference activity even at the highest siRNA concentration (26 nm).
The above results indicate that, in general, incorporation of one to three nucleotides in the guide strand is well tolerated by the RNAi machinery. However, the North 2'-deoxy-MC modification is not tolerated when the oligoribonucletides contain more than six substitutions. On the other hand, introduction of T N modifications in the 3'-overhangs in the antisense (13), sense (14), or both strands (15) In the report by ElmØn et al. it was suggested that introduction of a single LNA modification at the 5'-terminal end (position 1) of the sense strand allows preferential incorporation of the guide strand into the RISC, thereby improving gene-silencing efficiency and reducing the sense-strand-specific off-targeting activity. [10e] Although North 2'-deoxy-MC nucleosides and LNAs are different in structure, both possess conformationally restricted ring systems and are bridged bicyclic compounds. In order to study the effect of the modification of the sense strand with a T N residue we chose the neighboring position (position 2; siRNA 16, Figure 1 B) . Interestingly, the resulting siRNA (16) displayed activity slightly better than that of the unmodified siRNA 1 (Figure 1 A and Figure S1 D; Bonferroni test, p < 0.05). At an siRNA concentration of 0.03 nm, (44 AE 1) % gene knockdown was observed for 16,versus (32 AE 4) % gene knockdown for 1. Gene silencing was comparable to that observed for the 3'-modified siRNA 7, containing a single T N substitution at position 20 in the guide strand.
To ensure the specificity of the effects described above, sequence-scrambled siRNAs (as negative controls) were used. Cells co-transfected with scrambled versions of the unmodified siRNA 1 (scr) and scrambled versions of two of the more active chemically modified siRNAs (10 and 16) displayed Renilla luciferase activities similar to those of cells transfected with plasmids alone (see data in Figure 1 A and in Figures S3 and S4) . These results indicate that the siRNAs used in this study specifically induce inhibition of expression of the target gene.
Finally, we compared the RNAi activities of one of the most active and one of the less active T N -modified siRNAs (7 and 11, respectively) versus their LNA-modified versions [siRNA 17, which contains a single LNA thymine substitution (T L ) at position 20 in the guide strand, and siRNA 18, which contains six T L residues at spaced-out positions along the guide strand). The results are represented in Figure 1 C. Interestingly, SH-SY5Y cells cotransfected with the T N -modified siRNAs 7 and 11 together with plasmids encoding Renilla and firefly luciferase 1060 www.chembiochem.org genes showed gene-silencing activities comparable to those of cells transfected with their LNA-modified versions (siRNAs 17 and 18, respectively) and the luciferase plasmids.
RNAi activities of T N -modified siRNAs targeting murine TNF-a TNF-a (a pro-inflammatory cytokine) is a major mediator of apoptosis, inflammation, and immunity. Furthermore, TNF-a has been implicated in the pathogenesis of many human diseases, such as Crohn's disease, which is an inflammatory disorder. Efficient knockdown of this factor could therefore have beneficial consequences for human health. Our group has been interested in the development of anti-inflammatory siRNAs to treat Crohn's disease. In recent studies we have developed new delivery systems, involving conjugation of lipids and peptides to the ends of an siRNA targeting murine TNF-a mRNA. [20] On the other hand, this work is aimed at increasing the binding affinities and nuclease stabilities of these siRNAs. For these reasons, the effect of T N -modified siRNAs on the inhibition of expression of murine TNF-a gene were examined.
Two of the most promising modified siRNA designs, corresponding to the siRNAs 7 and 16, were selected from our previous luciferase gene-silencing results and used for targeting murine TNF-a mRNA in RAW cells (murine peritoneal macrophages) with use of a previously reported sequence [20] (see the sequence in Figure 2 A) . We synthesized the unmodified siRNA 19 and the T N -modified siRNAs 20 and 21 targeting murine TNF-a (Figure 2 A) , containing T N modifications at the same positions as in the siRNAs 7 and 16 [one T N substitution at position 20 in the guide strand (20) and one T N substitution at position 2 in the sense strand (21)]. Moreover, we synthesized two disubstituted siRNAs targeting murine TNF-a, one of them (22) containing T N modifications at positions 6 and 20 in the guide strand, and the second one (23) containing T N modifications at positions 2 and 18 in the sense strand. Levels of TNF-a protein after treatment of the cells with siRNAs (100 nm concentration per well) were analyzed by enzyme-linked immunoabsorbent assay (ELISA; Figure 2 B ). Gene-silencing experiments were carried out in triplicate and included controls in which cells were treated with a non-targeting, scrambled siRNA (scr), selected from our luciferase siRNA assays. The disubstituted siRNAs 22 and 23 were the least potent of the set but still demonstrated gene-silencing activity. On the other hand, the monosubstituted siRNAs 20 and 21, containing the T N modification at the same positions as in the most active siRNAs targeting Renilla luciferase, silenced the expression of murine TNF-a, with activities comparable to that of the unmodified siRNA (19) . These results suggest that the most effective patterns of modification that emerged from the Renilla luciferase studies (which involved one T N substitution) could be used to target a wide variety of mRNA targets, whereas two T N substitutions seem to be less tolerated by this endogenous gene.
Immunostimulation
It is known that siRNAs can induce strong interferon-a (IFN-a) responses in human peripheral blood mononuclear cells (PBMCs). [8] In order to investigate whether or not T N -modified siRNAs can reduce the undesired immunostimulatory activity in PBMCs, we treated human PBMCs with the unmodified siRNA 19 (which is known to have immunostimulatory activity in human PBMCs) and with the T N -modified siRNAs that had been used for targeting TNF-a in murine peritoneal macrophages (20, 21, 22, and 23 ) at a 10 nm siRNA concentration with use of DOTAP as the delivery system. After siRNA transfection, immunostimulated PBMCs produce an array of cytokines including hTNF-a, IFN-a, and IL-6, from which hTNF-a was selected and measured 24 h after transfection as an indicator of immunomodulation in our experiments (Figure 3) . It is important to mention that the murine anti-TNF-a siRNAs 19-23 do not inhibit expression of hTNF-a. Treatment of human PBMCs with the siRNA 20 resulted in immunostimulation levels comparable to those obtained for the unmodified siRNA 19. However, incorporation of one T N substitution at position 2 in the sense strand (siRNA 21) and two substitutions at positions 6 and 20 in the guide strand (siRNA 22) leads to immunostimulation levels significantly lower than those obtained for the unmodified siRNA (19) . Production of hTNF-a (pg mL À1 ) was 299 AE 18 for 21 and 286 AE 33 for 22, versus 390 AE 35 for 19 (Bonferroni test, p < 0.05). Moreover, the sense-disubstituted siRNA 23 leads to immunostimulation levels even lower than those obtained for the siRNAs 21 and 22 (217 AE 33 pg mL À1 hTNF-a for 23 versus 390 AE 35 pg mL À1 hTNF-a for 19; p < 0.005). These results suggest that T N replacement along the guide or the sense strand in siRNA reduces induction of hTNFa in PBMCs and that this effect depends on the positions and numbers of T N substitutions.
Serum stabilities of North 2'-deoxy-MC thymine-modified siRNAs
Because the above experiments showed that most of the T Nmodified siRNAs tested were capable of effective mediation of RNAi to levels comparable to that obtained with the wild-type siRNA, and that the T N modification can be used to increase the thermal stabilities of siRNA duplexes, it was of interest to study the serum stabilities of these oligonucleotides. To carry out such studies, unmodified or modified double-stranded RNAs were incubated in human serum (50 %). At various time points, siRNAs were extracted, analyzed on a polyacrylamide gel (14 %) under denaturing conditions, and visualized by staining. Here we describe the most representative examples: the unmodified oligoribonucleotide 1 and the siRNAs 11, 15, and 16 (Figure 4 and Figure S2 ). The SiRNA 15 was designed to enhance exonuclease resistance (it contains T N modifications at both 3'-ends). The SiRNA 11, which contains five substitutions at base-paired positions in the guide strand, was designed to increase the thermal stability of the duplex. Finally, the siRNA 16 (one T N base-paired substitution in the sense strand) is one of the most active oligonucleotides.
The T N -modified siRNAs displayed higher serum stabilities than the unmodified siRNA 1. As shown in Figure 4 and in Figure S2 , the unmodified siRNA (1) was rapidly degraded, with 27, 4, and 0 % of the original siRNA remaining intact through 4, 7, and 9 h, respectively. Modification of both 3'-dinucleotide ends of the siRNA (siRNA 15) gave rise to an increase in the serum stability of the duplex, with 52 %, 25 %, and 20 % of the original siRNA remaining intact through 4, 7, and 9 h, respectively. Similar results were obtained for siRNAs containing a single T N substitution at position 20 in the guide strand and modifications in the 3'-dinucleotide overhang in either strand of the duplex (siRNAs 7, 13, and 14, respectively; data not shown). On the other hand, the double-stranded siRNA with one T N residue at position 2 in the sense strand (16) demonstrated a significantly enhanced stability in the experiment, with 50 % of the original siRNA remaining intact through 9 h. Interestingly, the siRNA containing six T N substitutions (11) displayed strongly enhanced stability, with 84 % of the siRNA population remaining intact after 9 h. The original siRNA was completely degraded after 48 h in serum ( Figure S2 ). Similar results were obtained for the siRNA 12, which contains eleven T N substitutions in the guide strand (data not shown).
We can thus conclude that the T N modification confers a significant stabilization of siRNAs in serum.
Conclusions
In this work we have demonstrated that North 2'-deoxy-MC substitution is substantially compatible with the RNAi machinery. The gene-silencing activities of the corresponding modified siRNAs depend on the positions and the number of the substitutions. We have shown that incorporation of one to three substitutions into the guide strand is, in general, well tolerated in a luciferase system. In contrast, a greater number of substitutions is detrimental to activity, despite the enhanced serum and thermal stabilities of the corresponding modified siRNAs.
On the other hand, the T N -modified siRNAs that were compared with their LNA thymidine-modified counterparts showed 1062 www.chembiochem.org similar activities (siRNAs 7 and 11 versus siRNAs 17 and 18; see data in Figure 1 C) . Our results thus suggest that the effect on RNAi activity produced by the North 2'-deoxy-MC modification might be similar to that observed for the LNA substitution.
Moreover, the T N modification confers on siRNAs resistance against nucleases, and such stabilizing effects increase with the number of substitutions.
Finally, the North 2'-deoxy-MC can also be used in the design of anti-inflammatory siRNAs targeting murine TNF-a. In this case, innate immunostimulation effects are clearly reduced by the introduction of a few units of this pseudonucleoside. This result is in agreement with the general observation that modifications at the carbohydrate moiety can reduce immunostimulation. [21] In summary, from this work we can conclude that the effects of North 2'-deoxy-MC modification on RNAi are similar to those of LNA modification and therefore that North 2'-deoxy-MC nucleosides are promising candidates for the development of new RNA agents for biomedical applications of siRNAs. Moreover, alteration of the pseudosugar with different functional groups at the 2'-position might offer an avenue for the development of new potentially active MC-modified siRNAs.
In these studies, we have demonstrated for the first time that siRNAs containing a constrained cyclopentane ring embedded in a bicyclo[3.1.0]hexane system can induce the RNAi process. These results are in agreement with previous studies reported by Hoshika et al. [22] that suggested that the oxygen atom of the ribose moiety was not necessary and that it could be replaced by a sulfur atom. This means that replacement of this oxygen by sulfur or a carbon might yield novel modified siRNAs with improved properties as long as the North sugar pucker is conserved.
Experimental Section
Nucleoside phosphoramidite synthesis: The 5'-O-DMT-protected 2'-deoxy-MC thymidine 3'-O-phosphoramidite was prepared as described. [23] Solid support functionalization: The polymer support was functionalized with North 2'-deoxy-MC thymidine as described for natural nucleosides. [24] Step I (preparation of 5'-O-DMT-protected North 2'-deoxy-MC thymidine-3'-O-succinate): Succinic anhydride (1.3 mmol), diisopropylethylamine (1.4 mmol) , and dimethylaminopyridine (0.1 equiv) were added to a solution of 5'-O-DMT-protected North 2'-deoxy-MC thymidine [18a, 24] (1 mmol) in dichloromethane (0.2 m). The resulting solution was stirred for 24 h at room temperature and then washed with sodium dihydrogen phosphate (1 %). The aqueous layer was extracted with CH 2 Cl 2 and the organic layer was dried with MgSO 4 and concentrated.
Step II: 2,2'-Dithio-bis-(5-nitropyridine) (0.1 mmol), dissolved in a acetonitrile/dichloroethane mixture (1:3, 400 mL), was mixed with a solution of 5'-O-DMT-protected North 2'-deoxy-MC thymidine-3'-Osuccinate (0.1 mmol) and DMAP (0.1 mmol) in acetonitrile (500 mL). The obtained clear solution was added at room temperature to a solution of triphenylphosphine (0.1 mmol) in acetonitrile (200 mL). The mixture was vortexed for few seconds and then added to a vial containing CPG (500 , 500 mg) and allowed to react for 30 min at room temperature. Methanol (500 mL) was then added and the support was recovered on a sintered glass funnel, followed by washings with methanol (2 5 mL) and diethyl ether (2 5 mL). The support was air-dried and then placed under high vacuum.
The support was subjected to capping by the standard protocol. [25] The North 2'-deoxy-MC thymidine loading on the derivatized support was determined by the acid treatment method. [25] RNA synthesis and purification methods: RNA oligonucleotides were synthesized on the 0.2 mmol scale with an Applied Biosystems 394 synthesizer and use of 2'-O-TBDMS-protected phosphoramidites. Acetonitrile (synthesis grade) and the 2'-O-TBDMS-protected phosphoramidite monomers of A, C, G, and U were from commercial suppliers. Tetrazole was used as activator. The coupling time was 15 min. P(III) to P(V) oxidation was performed with a solution of tert-butyl hydroperoxide (10 %) in acetonitrile/water (96:4) with a 10 min oxidation time. Chemical phosphorylation reagent procured from Link Technologies was used to phosphorylate the 5'end of a modified oligonucleotide. All oligonucleotides were synthesized in DMT-on mode. After the solid-phase synthesis, the solid support was transferred to a screw-cap glass vial and incubated at 55 8C for 1 h with NH 3 solution (33 %, 1.5 mL) and ethanol (0.5 mL). The vial was then cooled on ice and the supernatant was transferred to a 2 mL Eppendorf tube. The solid support and vial were rinsed with ethanol (50 %, 2 0.25 mL). The combined solutions were concentrated to dryness with an evaporating centrifuge. The residue that was obtained was dissolved in TBAF in THF (1 m, total volume of 85 mL) and rocked at room temperature for 12 h. Triethylammonium acetate (1 m, 85 mL) and water (330 mL) were then added to the solution. The oligonucleotide was desalted on a NAP-5 column with water as the eluent and concentrated to dryness. The oligonucleotide was purified by high-performance liquid chromatography (HPLC; DMT-on). The HPLC conditions were as follows: column: PRP-1 (Hamilton) 250 10 mm; solvent A = 5 % acetonitrile in 100 mm triethylammonium acetate, pH 6.5; solvent B = 70 % acetonitrile in 100 mm triethylammonium acetate pH 6.5; gradient: 0-30 min, from 15 to 100 % in B with UV detection at 260 nm. The pure fractions were combined and concentrated to dryness. The residue that was obtained was treated with AcOH solution (80 %, 1 mL) and incubated at room temperature for 30 min. The deprotected oligonucleotide was desalted on a NAP-10 column with water as the eluent. All oligonucleotides were quantified by absorption at 260 nm and confirmed by MALDI mass spectrometry (see data in Table S1 ).
UV-monitored thermal denaturation studies: Absorbance versus temperature curves of duplexes were measured at 1 mm strand concentrations in HEPES-KOH (pH 7.4, 15 mm), MgCl 2 (1 mm), and KOAc (50 mm) buffer. Experiments were performed in Teflon-stoppered 1 cm path-length quartz cells with a JACSO V-650 spectrophotometer fitted with a thermoprogrammer. The samples were heated to 90 8C, allowed to cool slowly to 25 8C, and then warmed during the denaturation experiments at a rate of 1 8C min À1 to 85 8C, with monitoring of absorbance at 260 nm. The data were analyzed with the aid of the denaturation curve processing program, MeltWin v. 3.0. Melting temperatures (T m ) were determined by computerfit of the first derivative of absorbance with respect to 1/T. CD measurements: CD spectra were recorded with a Jasco J-810 spectropolarimeter fitted with a Julabo F/25HD temperature controller, with the same buffer conditions and oligonucleotide concentrations as for UV melting curves. All spectra were recorded at room temperature between 220 and 320 nm, with use of a Luciferase siRNA assays: SH-SY5Y cells were grown at 37 8C in Dulbecco's modified Eagle's medium (DMEM; GIBCO) supplemented with fetal bovine serum (FBS, 10 %), penicillin (100 U mL À1 ), and streptomycin (100 mg mL À1 ). Cells were regularly passaged to maintain exponential growth. Twenty-four hours before transfection at 50-80 % confluency, mammalian cells were trypsinized and diluted 1:5 with fresh medium without antibiotics (1-3 10 5 cells mL À1 ) and transferred to 24-well plates (500 mL per well). Two luciferase plasmids-Renilla luciferase (pRL-TK) and firefly luciferase (pGL3) from Promega-were used as a reporter and control, respectively. Cotransfection of plasmids and siRNAs was carried out with Lipofectamine 2000 (Life Technologies) as described by the manufacturer for adherent cell lines; pGL3-Control (1.0 mg), pRL-TK (0.1 mg), and siRNA duplex (0.03-26 nm) formulated into liposomes were added to each well with a final volume of 600 mL. The cells were harvested 22 h after transfection and lyzed with passive lysis buffer (100 mL per well) according to the instructions of the Dual-Luciferase Reporter Assay System (Promega). The luciferase activities of the samples were measured with a MicroLumaPlus LB 96V (Berthold Technologies) with a delay time of 2 s and an integrate time of 10 s. The following volumes were used: 20 mL of sample and 30 mL of each reagent (Luciferase Assay Reagent II and Stop and Glo Reagent). The inhibitory effects generated by siRNAs were expressed as normalized ratios between the activities of the reporter (Renilla) luciferase gene and the control (firefly) luciferase gene.
TNF-a siRNA assays: siRNA inhibition experiments with the endogeneous target murine TNF-a were performed with RAW 264.7 cells (murine peritoneal macrophages). RAW 264.7 cells were grown at 37 8C in Dulbecco's modified Eagle's medium (DMEM; GIBCO) supplemented with fetal bovine serum (FBS, 10 %), penicillin (100 U mL À1 ), streptomycin (100 mg mL À1 ), and glutamine (10 %). Cells plated at 40-60 % confluence in 96-well plates were transfected with the aid of DOTAP {N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulfate} at an siRNA concentration of 100 nm according to the manufacturer's protocol. Experiments were carried out in triplicate. 20 h after transfection, the cells were stimulated with LPS (lipopolysaccharide of Gram-negative bacteria, 10 ng mL À1 ) for 10 h and the amount of murine TNF-a produced by the cells (contained in the supernatants from cells) was analyzed by enzyme-linked immunoabsorbent assay (ELISA).
Cell stimulation and hTNF-a detection: PBMC cells were obtained from human blood by Ficoll density gradient separation. Enriched monocyte populations were isolated by plastic adherence. After three hours of incubation at 37 8C, cells were transfected with siRNAs (10 nm) for 18 h by use of DOTAP (Roche) following the manufacturer's instructions. Culture supernatants were then collected and hTNF-a production upon immunostimulation was assessed by ELISA (Bender MedSystems). Experiments were carried out in triplicate Statistical analysis: Data were analyzed by use of the GraphPad Prism 5 program (GraphPad Software). Significant differences were assessed by ANOVA to compare three or more groups followed by Bonferroni test. In all figures, * represents p values < 0.05.
Stability assays in human serum (50 %): Unmodified or modified double-stranded siRNA samples (20 mm, 24 mL) were incubated in human serum (24 mL) at 37 8C. At appropriate periods (0, 0.5, 1, 2, 4, 7, and 9 h), aliquots (6 mL) of the reaction mixture were added to aqueous sodium dodecyl sulfate solution (1 %, 54 mL) and the mixtures were heated-denatured for 5 min at 90 8C. SiRNAs were isolated by hot phenol extraction followed by ethanol precipitation. After re-suspension in loading buffer [formamide (90 %), 1 TBE (10 %), 20 mL], the samples were run on a denaturing polyacrylamide gel (14 %) containing formamide (20 %). RNA bands were visualized with the SYBR Green II reagent (Sigma-Aldrich) according to the manufacturer's instructions.
